Diagnósticos da América S.A. (BOVESPA:DASA3) agreed to acquire AmeriMed American Hospitals on January 13, 2022. The superintendent of Brazilian antitrust body Cade has approved medical diagnostic firm Dasa's acquisition of control in the Grupo Marimed hospital group, without restrictions.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
4.3 BRL | +0.70% | +16.85% | -55.30% |
16/05 | Transcript : Diagnósticos da América S.A., Q1 2024 Earnings Call, May 16, 2024 | |
06/05 | Diagnósticos da América S.A.(BOVESPA:DASA3) added to Brazil Corporate Sustainability Index | CI |
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
-55.30% | 620M | |
+17.74% | 83.47B | |
-29.66% | 69.72B | |
-0.49% | 26.22B | |
+4.03% | 17.69B | |
-12.16% | 16.83B | |
+2.47% | 15.7B | |
+74.82% | 13.45B | |
+73.52% | 12.81B | |
-0.76% | 12.69B |
- Stock Market
- Equities
- DASA3 Stock
- News Diagnosticos da América S.A.
- Diagnósticos da América S.A. agreed to acquire AmeriMed American Hospitals.